Virgolini I, Bahri S, Kjaer A, Gronbaek H, et al. A Randomized, Factorial Phase II Study to Determine the Optimal Dosing Regimen for (68)Ga-Satoreotide Trizoxetan as an Imaging Agent in Patients with Gastroenteropancreatic Neuroendocrine Tumors. J Nucl Med 2022;63:376-383.
PMID: 34215673